StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
147
This year
9
Publishing Date
2024 - 01 - 09
2
2023 - 11 - 07
2
2023 - 05 - 08
2
2022 - 12 - 01
2
2022 - 08 - 18
2
2022 - 08 - 08
2
2022 - 06 - 17
2
2021 - 11 - 19
2
2021 - 11 - 17
2
2021 - 10 - 26
2
2021 - 10 - 19
1
2021 - 09 - 30
1
2021 - 09 - 28
1
2021 - 09 - 24
1
2021 - 09 - 18
1
2021 - 09 - 09
1
2021 - 09 - 01
1
2021 - 08 - 26
1
2021 - 08 - 25
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 16
2
2021 - 08 - 05
1
2021 - 07 - 23
1
2021 - 07 - 21
1
2021 - 07 - 19
1
2021 - 07 - 14
1
2021 - 07 - 08
1
2021 - 06 - 30
1
2021 - 06 - 10
1
2021 - 05 - 28
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 07
1
2021 - 05 - 06
1
2021 - 04 - 19
1
2021 - 04 - 12
1
2021 - 04 - 01
1
2021 - 03 - 31
1
2021 - 03 - 26
1
2021 - 03 - 24
1
2021 - 03 - 11
1
2021 - 03 - 08
1
2021 - 02 - 25
1
2021 - 02 - 19
1
2021 - 02 - 18
1
2021 - 02 - 17
3
2021 - 02 - 12
1
2021 - 02 - 08
1
2021 - 02 - 01
1
2021 - 01 - 26
1
2021 - 01 - 20
1
2021 - 01 - 08
1
2020 - 12 - 29
1
2020 - 12 - 28
1
2020 - 12 - 23
2
2020 - 12 - 21
1
2020 - 12 - 14
1
2020 - 12 - 12
1
2020 - 12 - 10
1
Sector
Commercial services
1
Communications
22
Consumer durables
2
Distribution services
1
Finance
3
Health technology
147
Manufacturing
2
N/a
1
Process industries
1
Professional, scientific, and technical services
4
Tags
Acquisition
2
Agreement
2
Announces collaboration
3
Antibody
3
Application
9
Approval
4
Arv-471
7
Authorization
10
Authorized
5
Biopharma
3
Breast
9
Breast cancer
2
Cancer
13
Candidate
8
Children
11
Chmp
4
Collaboration
6
Comirnaty®
9
Conference
4
Covid
34
Covid-19
26
Designation
4
Disease
10
Drug
6
Emergency use authorization
7
Europe
3
Fda
24
Financial
7
Kisqali
4
License
5
Management
3
Medical
3
Merge
8
Myfembree
4
N/a
147
Novartis
4
Order
6
Phase 2
5
Phase 3
8
Positive
11
Program
5
Report
3
Response
4
Results
14
Risk
4
Sars-cov-2
3
Sciences
4
Study
3
Submission
4
Symposium
4
Therapeutics
8
Therapy
5
Topline
3
Treatment
5
Trial
10
Update
8
Vaccine
63
Valneva
7
Vla15
3
Women
4
Entities
Abbvie inc.
1
Aerovate therapeutics inc
1
Agex therapeutics, inc.
1
Akero therapeutics, inc.
1
Altimmune, inc.
1
Arbutus biopharma corporation
1
Arrival
1
Arvinas, inc.
16
Atossa therapeutics, inc.
1
Bank of montreal
1
Biocryst pharmaceuticals, inc.
1
Biogen inc.
1
Biontech se
69
Caribou biosciences inc
1
Cellectis s.a.
1
Clearside biomedical, inc.
1
Crispr therapeutics ag
1
Dyadic international, inc.
1
Eli lilly and company
3
Endo international plc
1
Esperion therapeutics, inc.
1
Genmab a/s
3
Gilead sciences, inc.
1
Glaxosmithkline plc
1
Global blood therapeutics, inc.
1
Immix biopharma, inc.
1
Ingredion incorporated
1
Landos biopharma inc
1
Lianbio - adr
2
Morgan stanley
1
Myovant sciences ltd.
12
Nasdaq, inc.
1
Novan, inc.
1
Novartis ag
5
Opko health, inc.
1
Orange
22
Pfizer, inc.
147
Phasebio pharmaceuticals, inc.
1
Pool corporation
1
Pyxis oncology inc
1
Qualigen therapeutics, inc.
1
Roivant sciences ltd.
1
Sanofi
51
Sarepta therapeutics, inc.
1
Seagen inc.
1
Spero therapeutics, inc.
3
Take-two interactive software, inc.
1
Vericel corporation
1
Veru inc.
1
Voyager therapeutics, inc.
2
Whirlpool corporation
1
Symbols
APO
348
ARVL
694
BKYI
195
BLK
356
BLNK
178
BMO
378
BNPQF
1342
BNPQY
1342
CM
210
CNHI
256
CNI
211
EQNR
297
FBIO
178
FCN
241
FNCTF
1138
FRBA
338
GMAB
227
GNMSF
174
GOLD
260
HII
314
JG
198
JNJ
551
LLY
200
LPLA
290
LTUM
308
MS
1198
MT
228
NDAQ
410
NOK
656
NOKBF
623
NVDA
199
NVO
342
NVS
226
NVSEF
173
PHG
210
PPRUF
366
PPRUY
366
RACE
195
RCI
181
RXT
228
RY
280
SNY
784
SNYNF
575
STLA
266
STM
272
STMEF
193
STOHF
230
TECK
199
TIXT
176
TNXP
192
TOL
389
TRP
177
TRU
242
TU
336
VRSK
181
VZ
892
WKEY
234
XELA
197
XYF
259
ZEAL
189
Exchanges
Amex
1
Nasdaq
117
Nyse
147
Crawled Date
2024 - 01 - 09
2
2023 - 11 - 07
2
2023 - 10 - 16
2
2023 - 05 - 08
2
2022 - 12 - 01
2
2022 - 08 - 18
2
2022 - 08 - 08
2
2022 - 06 - 17
2
2021 - 11 - 19
2
2021 - 11 - 17
2
2021 - 10 - 26
2
2021 - 09 - 30
1
2021 - 09 - 28
1
2021 - 09 - 24
1
2021 - 09 - 18
1
2021 - 09 - 09
1
2021 - 09 - 01
1
2021 - 08 - 26
1
2021 - 08 - 25
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 16
2
2021 - 08 - 05
1
2021 - 07 - 23
1
2021 - 07 - 21
1
2021 - 07 - 19
1
2021 - 07 - 14
1
2021 - 07 - 08
1
2021 - 06 - 30
1
2021 - 06 - 10
1
2021 - 05 - 28
1
2021 - 05 - 20
1
2021 - 05 - 11
1
2021 - 05 - 07
1
2021 - 05 - 06
1
2021 - 04 - 19
1
2021 - 04 - 12
1
2021 - 04 - 01
1
2021 - 03 - 31
1
2021 - 03 - 26
1
2021 - 03 - 24
1
2021 - 03 - 11
1
2021 - 03 - 08
1
2021 - 02 - 25
1
2021 - 02 - 19
1
2021 - 02 - 18
1
2021 - 02 - 17
3
2021 - 02 - 12
1
2021 - 02 - 08
1
2021 - 02 - 01
1
2021 - 01 - 26
1
2021 - 01 - 20
1
2021 - 01 - 08
1
2020 - 12 - 29
1
2020 - 12 - 28
1
2020 - 12 - 23
2
2020 - 12 - 21
1
2020 - 12 - 14
1
2020 - 12 - 12
1
2020 - 12 - 11
1
Crawled Time
00:00
3
00:01
1
04:00
1
04:20
1
05:00
4
06:00
4
06:03
2
07:00
4
08:20
1
09:00
1
09:01
1
10:00
2
11:00
29
11:01
1
12:00
25
12:03
1
12:15
1
12:20
3
12:30
2
13:00
4
13:01
1
13:15
1
13:20
2
13:30
2
14:00
9
14:20
2
15:00
4
15:20
1
16:00
6
16:20
1
17:00
2
18:00
1
19:00
3
19:25
1
20:00
2
21:00
8
22:00
3
22:04
1
23:00
6
Source
ir.akerotx.com
2
ir.vaccinex.com
1
ir.voyagertherapeutics.com
3
mindmed.co
1
www.4dpharmaplc.com
1
www.achievelifesciences.com
2
www.biospace.com
260
www.chi-med.com
1
www.eyenoviabio.com
1
www.fda.gov
31
www.globenewswire.com
147
www.prnewswire.com
242
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Pfe
source :
Www.globenewswire.com
save search
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Published:
2024-03-26
(Crawled : 21:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-7.87%
|
O:
0.43%
H:
0.81%
C:
0.25%
therapeutics
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Published:
2024-03-19
(Crawled : 11:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-8.3%
|
O:
-0.18%
H:
0.4%
C:
-0.14%
pharmaceuticals
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Published:
2024-03-18
(Crawled : 21:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-8.3%
|
O:
-0.18%
H:
0.4%
C:
-0.14%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
-21.5%
|
O:
-3.22%
H:
4.58%
C:
3.23%
medical
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-10.4%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
2.23%
|
O:
0.9%
H:
2.03%
C:
1.89%
VERU
|
$1.42
22.41%
18.31%
7M
|
Health Technology
|
115.81%
|
O:
-0.53%
H:
2.22%
C:
-3.59%
ALT
|
$6.9
-1.99%
-2.03%
3.2M
|
Commercial Services
|
-30.19%
|
O:
0.3%
H:
11.41%
C:
9.8%
medical
program
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-6.48%
|
O:
-0.22%
H:
0.29%
C:
-0.85%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
-31.46%
|
O:
0.0%
H:
1.25%
C:
-1.6%
year
update
financial
results
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
Published:
2024-02-06
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-4.33%
|
O:
0.34%
H:
3.99%
C:
3.15%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
-27.78%
|
O:
0.91%
H:
5.05%
C:
4.9%
arv-471
fda
breast
cancer
treatment
designation
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
Published:
2024-02-02
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
0.08%
|
O:
-0.78%
H:
0.3%
C:
-0.84%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-6.85%
|
O:
-0.4%
H:
0.07%
C:
-0.92%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
1.28%
|
O:
-1.21%
H:
0.72%
C:
-0.11%
authorization
cancer
treatment
application
TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer
Published:
2024-01-09
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-15.94%
|
O:
-3.69%
H:
1.71%
C:
-2.41%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-14.06%
|
O:
0.07%
H:
0.88%
C:
-0.68%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-12.94%
|
O:
-1.1%
H:
0.46%
C:
-0.06%
tivdak
drug
license
review
food
cancer
application
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-09
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-14.06%
|
O:
0.07%
H:
0.88%
C:
-0.68%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-22.98%
|
O:
-2.48%
H:
0.82%
C:
-0.37%
conference
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
Published:
2023-12-14
(Crawled : 12:30)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-4.65%
|
O:
0.38%
H:
2.07%
C:
-2.35%
Update: Annual Changes to the Nasdaq-100® Index
Published:
2023-12-12
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-11.06%
|
O:
-8.05%
H:
1.71%
C:
1.45%
TTWO
4
|
$140.64
-1.76%
-1.79%
1.5M
|
Consumer Durables
|
-8.93%
|
O:
2.51%
H:
1.8%
C:
1.23%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
-0.05%
|
O:
0.03%
H:
0.01%
C:
-0.08%
NDAQ
|
$60.075
0.11%
0.11%
2.3M
|
Finance
|
10.78%
|
O:
0.11%
H:
4.08%
C:
3.98%
100
index
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published:
2023-12-08
(Crawled : 14:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-11.21%
|
O:
0.07%
H:
1.1%
C:
0.45%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-2.97%
|
O:
0.19%
H:
0.35%
C:
0.2%
kisqali
breast
risk
novartis
Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program
Published:
2023-12-06
(Crawled : 04:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-12.62%
|
O:
0.0%
H:
1.07%
C:
-1.03%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
44.32%
|
O:
5.35%
H:
26.96%
C:
24.13%
arv-471
conference
breast
symposium
cancer
program
Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Program
Published:
2023-12-05
(Crawled : 19:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-12.62%
|
O:
0.0%
H:
1.07%
C:
-1.03%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
44.32%
|
O:
5.35%
H:
26.96%
C:
24.13%
ibrance
program
trial
Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15
Published:
2023-12-04
(Crawled : 21:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-13.18%
|
O:
-0.24%
H:
1.34%
C:
-0.41%
vla15
disease
vaccine
valneva
trial
Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium
Published:
2023-11-28
(Crawled : 22:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-14.38%
|
O:
0.27%
H:
1.51%
C:
1.04%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
36.94%
|
O:
1.72%
H:
4.07%
C:
0.6%
arv-471
breast
symposium
cancer
Arvinas Announces Oversubscribed $350 Million Private Placement
Published:
2023-11-27
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-16.66%
|
O:
0.82%
H:
0.0%
C:
-1.98%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
52.9%
|
O:
2.51%
H:
11.93%
C:
7.54%
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-11-07
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-18.47%
|
O:
-0.32%
H:
0.98%
C:
0.55%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
97.52%
|
O:
1.0%
H:
4.2%
C:
4.04%
update
financial
results
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference
Published:
2023-11-07
(Crawled : 06:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-18.47%
|
O:
-0.32%
H:
0.98%
C:
0.55%
conference
valneva
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-2.36%
|
O:
0.24%
H:
3.29%
C:
-1.11%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
2.04%
|
O:
0.16%
H:
0.0%
C:
0.0%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-18.68%
|
O:
0.19%
H:
0.29%
C:
-0.45%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.15%
|
O:
0.21%
H:
0.0%
C:
0.0%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-1.93%
|
O:
0.55%
H:
0.44%
C:
-1.37%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-10.03%
|
O:
5.74%
H:
3.18%
C:
-1.55%
update
financial
results
← Previous
1
2
3
4
5
6
7
8
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.